These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36676942)

  • 21. Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.
    Wish JB; Pergola P
    Mayo Clin Proc Innov Qual Outcomes; 2022 Dec; 6(6):536-551. PubMed ID: 36277502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between kidney disease and diabetes: dangerous liaisons.
    Pecoits-Filho R; Abensur H; Betônico CC; Machado AD; Parente EB; Queiroz M; Salles JE; Titan S; Vencio S
    Diabetol Metab Syndr; 2016; 8():50. PubMed ID: 27471550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictive factors in diabetic kidney disease progression.
    Radcliffe NJ; Seah JM; Clarke M; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Investig; 2017 Jan; 8(1):6-18. PubMed ID: 27181363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
    Huang B; Wen W; Ye S
    Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cadmium turnover and changes of zinc and copper body status of rats continuously exposed to cadmium and ethanol.
    Brzóska MM; Moniuszko-Jakoniuk J; Jurczuk M; Gałazyn-Sidorczuk M
    Alcohol Alcohol; 2002; 37(3):213-21. PubMed ID: 12003907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of and risk factors for the development and progression of diabetic kidney disease.
    Macisaac RJ; Ekinci EI; Jerums G
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Diabetic Kidney Disease in Type 2 Diabetic Patients: Prevalence, Clinical Predictors and Outcomes.
    Erdogmus S; Kiremitci S; Celebi ZK; Akturk S; Duman N; Ates K; Erturk S; Nergizoglu G; Kutlay S; Sengul S; Ensari A; Keven K
    Kidney Blood Press Res; 2017; 42(5):886-893. PubMed ID: 29130997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ion channels and transporters in diabetic kidney disease.
    Spires D; Manis AD; Staruschenko A
    Curr Top Membr; 2019; 83():353-396. PubMed ID: 31196609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Concentrations of Copper, Zinc, and Iron are Associated With Increased Levels of Glycated Hemoglobin in Patients With Type 2 Diabetes Mellitus and Their First-Degree Relatives.
    Atari-Hajipirloo S; Valizadeh N; Khadem-Ansari MH; Rasmi Y; Kheradmand F
    Int J Endocrinol Metab; 2016 Apr; 14(2):e33273. PubMed ID: 27761143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators.
    Zheng Y; Li XK; Wang Y; Cai L
    Hemoglobin; 2008; 32(1-2):135-45. PubMed ID: 18274991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Urinary Sodium Excretion and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
    Huang Y; Liu W; Liu J; Guo D; Zhang P; Liu D; Lin J; Yang L; Zhang H; Xue Y
    Front Endocrinol (Lausanne); 2021; 12():772073. PubMed ID: 34777262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop.
    Zhou Y; Ma XY; Han JY; Yang M; Lv C; Shao Y; Wang YL; Kang JY; Wang QY
    World J Diabetes; 2021 Jan; 12(1):19-46. PubMed ID: 33520106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.
    Issar T; Arnold R; Kwai NCG; Walker S; Yan A; Borire AA; Poynten AM; Pussell BA; Endre ZH; Kiernan MC; Krishnan AV
    Clin Neurophysiol; 2019 Nov; 130(11):2088-2095. PubMed ID: 31541986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of chronic diabetes on tissue and blood cells status of zinc, copper, and chromium in the rat.
    Raz I; Havivi E
    Diabetes Res; 1988 Jan; 7(1):19-23. PubMed ID: 3402163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.
    Gembillo G; Ingrasciotta Y; Crisafulli S; Luxi N; Siligato R; Santoro D; Trifirò G
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.